| Dokumendiregister | Ravimiamet |
| Viit | REP-1/1197-2 |
| Registreeritud | 05.03.2025 |
| Sünkroonitud | 06.03.2025 |
| Liik | Väljaminev kiri |
| Funktsioon | REP Euroopa Farmakopöaga seotud asjaajamine |
| Sari | REP-1 Euroopa Farmakopöa alane kirjavahetus |
| Toimik | REP-1/2025 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | European Directorate for the Quality of Medicines & HealthCare |
| Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
| Vastutaja | Signe Leito (RA, Peadirektori asetäitja valdkond, Labor) |
| Originaal | Ava uues aknas |
Addition to the work programme of Group 17 – Sodium Patent Blue and Sodium Patent Blue solution for injection
page 1 / 4
Q1-4 (3949)
NPA: (51425) Type: (!/list-dropdown)
A10 - Estonia (EE)
Please inform if you are in favour of the addition of the monograph on Sodium Patent Blue to
the work programme:
(51426) Type: (L/list-radio)
Not interested
A2
If opposed to this addition to the work programme, please state why. (51427) Type: (T/text-long)
-
page 2 / 4
Please inform if you are in favour of the addition of the monograph on Sodium Patent Blue
solution for injection to the work programme:
(51429) Type: (L/list-radio)
Not interested
A2
If opposed to this addition to the work programme, please state why. (51428) Type: (T/text-long)
-
Could you please provide the contact details (e.g. e-mail address, if available) of approved
manufacturers for Sodium Patent Blue and Sodium Patent Blue solution for injection in your
country? (51431) Type: (T/text-long)
n.a
Remarks: (51430) Type: (T/text-long)
-
page 3 / 4
Powered by TCPDF (www.tcpdf.org)
page 4 / 4
| Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
|---|---|---|---|---|---|---|
| Euroopa farmakopöa töökava asjus | 05.03.2025 | 1 | REP-1/1197-1 | Sissetulev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |